Bioceltix S.A. (WSE:BCX)
Poland
· Delayed Price · Currency is PLN 104.00
-1.00 (-0.95%)
Aug 14, 2025, 4:45 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 517.07 million as of August 14, 2025. Its market cap has increased by 63.55% in one year.
Market Cap
517.07M
Enterprise Value
485.16M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
104.00
Market Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 517.07M, an increase of 349.48%. That is a compound annual growth rate of 49.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 517.07M | 19.86% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.74B |
| NEUCA | 2.94B |
| Voxel | 1.87B |
| Synektik Spólka Akcyjna | 1.84B |
| Celon Pharma | 1.24B |
| Ryvu Therapeutics | 700.54M |
| Selvita | 603.90M |
| Centrum Medyczne ENEL-MED | 545.81M |